Bank of New York Mellon Corp - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 119 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$8,072,104
-60.7%
861,484
+2.9%
0.00%
-50.0%
Q2 2023$20,531,412
+7.2%
836,992
+1.7%
0.00%0.0%
Q1 2023$19,155,119
-9.5%
823,168
-1.6%
0.00%
-20.0%
Q4 2022$21,169,283
+50.4%
836,400
+14.6%
0.01%
+66.7%
Q3 2022$14,077,000
-21.3%
730,087
+4.0%
0.00%
-25.0%
Q2 2022$17,880,000
+153.3%
701,993
+155.7%
0.00%
+300.0%
Q1 2022$7,060,000
-39.5%
274,503
-1.6%
0.00%
-50.0%
Q4 2021$11,677,000
+2.5%
278,884
+6.5%
0.00%0.0%
Q3 2021$11,392,000
+0.4%
261,752
+9.1%
0.00%0.0%
Q2 2021$11,342,000
+29.2%
239,891
+40.0%
0.00%0.0%
Q1 2021$8,782,000
+80.9%
171,306
-5.5%
0.00%
+100.0%
Q4 2020$4,854,000
-14.3%
181,225
+9.8%
0.00%0.0%
Q3 2020$5,664,000
+11.6%
165,006
+33.3%
0.00%0.0%
Q2 2020$5,073,000
+654.9%
123,830
+531.2%
0.00%
Q1 2020$672,000
+312.3%
19,617
+51.6%
0.00%
Q4 2019$163,00012,9430.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$14,609,16117.42%
SB INVESTMENT ADVISERS (UK) LTD 16,684,041$156,329,4641.29%
Octagon Capital Advisors LP 325,050$3,045,7190.47%
SECTOR GAMMA AS 148,538$1,391,8010.36%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 1,345,635$12,608,6000.31%
ALGERT GLOBAL LLC 449,685$4,2140.20%
Quantamental Technologies LLC 18,519$173,5230.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 47,000$439,9200.15%
DUALITY ADVISERS, LP 123,871$1,160,6710.14%
Empowered Funds, LLC 385,135$3,608,7150.11%
View complete list of VIR BIOTECHNOLOGY INC shareholders